Evidence map›Paper›PMID 33868812›Full record

ArticlePeerJ2021

Serum

Xulong Cai, Qiaolan Xu, Chenrong Zhou, Tongjin Yin, Li Zhou

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PeerJ, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Xulong CaiDepartment of Pediatrics, Yancheng Third People's Hospital, Yancheng, China.
Qiaolan XuDepartment of Pediatrics, Yancheng Third People's Hospital, Yancheng, China.
Chenrong ZhouDepartment of Pediatrics, Yancheng Third People's Hospital, Yancheng, China.
Tongjin YinDepartment of Pediatrics, Yancheng Third People's Hospital, Yancheng, China.
Li ZhouDepartment of Pediatrics, Yancheng Third People's Hospital, Yancheng, China.
Nanjing Medical University · CNYancheng Third People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDue to the lack of effective and feasible viral biomarkers to distinguish viral infection from bacterial infection, children often receive unnecessary antibiotic treatment. To identify serum

methodsThis retrospective study was conducted from January 1, 2019 to September 30, 2020 in Yancheng Third People's Hospital. Children with upper respiratory tract infection and exanthem subitum were recruited. The concentration of serum

resultsA total of 291 children included 36 with bacterial upper respiratory tract infection (median age, 13 months; 44.4% female), 197 with viral upper respiratory tract infection (median age, 12 months; 43.7% female) and 58 with exanthem subitum (median age, 13 months; 37.9% female). When the concentration of

conclusionsSerum

Indexed as

Exanthem subitumSerum β2-microglobulinUpper respiratory tract infectionsViral biomarker

Identifiers

PMID33868812
PMCPMC8034339
OpenAlexW3144105845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.